>
pdufa.bio

Botensilimab

Updated ยทnext FDA decision on the calendar

Botensilimab is a Agenus Inc program. Its next catalyst is a Readout in Sep 2027. Every date links its source.

AGEN catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Agenus Inc (AGEN). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Sep 2027AGEN

Questions

When is Botensilimab's next FDA decision or readout?

The next tracked catalyst for Botensilimab is a Readout in Sep 2027.

What happened at Botensilimab's most recent FDA decision?

No FDA decision for Botensilimab is in our archive yet.

Who makes Botensilimab?

Agenus Inc (AGEN).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.